Locations

Showing 1452 Locations
Sort by:
  • Be'er Ya'aqov, Israel

    Assaf-Harofeh Medical Center

    A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD • Randomized, Double-blind, Active Placebo-Controlled Pilot Study of MDMA-assisted Psychotherapy in People With Chronic PTSD • Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel • A Randomized, Clinical Trial of Oral Midazolam Versus Oral Ketamine for Sedation During Laceration Repair.

  • Beaumont, Texas, USA

    Beaumont Psychiatric Clinic

  • Beaver, Pennsylvania, USA

    Safety and Efficacy Study of Xyrem (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem (Sodium Oxybate) to Treat Fibromyalgia.

  • Beaverton, Oregon, USA

    Cornell Pain Clinic

  • Bedford, Texas, USA

    Gauri Junnarkar

  • Beech Grove, Indiana, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Beer Sheva, Israel

    The Efficacy of Midazolam & Ketamine Versus Midazolam & Fentanyl for Sedation in Ambulatory Colonoscopies • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Beer Yaakov, Israel

    A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel

  • Beersheba, Israel

    Soroka University Medical Center

  • Beeston, England, United Kingdom

    World Wide Clinical Trials

  • Beeville, Texas, USA

    Advanced Pain Relief Institute

  • Beijing, China

    Harris Bricken • Peking Union Medical College Hospital • Beijing Tiantan Hospital • Peking University First Hospital • Beijing Anzhen Hospital

    Ketamine and Postoperative Depressive Symptom-PASSION • Low-dose S-ketamine in Women With Prenatal Depression • Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression • Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression • A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Beirut, Lebanon

    Lebanese American University Medical Center • Lebanese American University

    The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation • Opioid Free Anesthesia in Bariatric Surgery • Opioid Free Anesthesia and Major Spine Surgery

  • Belgrade, Montana, USA

    Lattice Biologics

  • Bellaire, Texas, USA

    Houston Ketamine Therapeutics

    Sandhya Prashad • Sandhya J. Prashad, MD

  • Bellefontaine, Ohio, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Belleville, Illinois, USA

    Express Specialty Pharmacy

  • Belleville, Michigan, USA

    Prizm Pain Management Clinic

  • Bellevue, Washington, USA

    Point Ketamine • Northwest Ketamine Clinics

    Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Bellingham, Washington, USA

    King Health Associates

    Kimberly Rex

  • Belmont, Massachusetts, USA

    Mclean Hospital

    MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer • A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Belo Horizonte, Brazil

    Santa Casa de Misericórdia de Belo Horizonte

  • Bemidji, Minnesota, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Benzonia, Michigan, USA

    Safety and Efficacy Study of Xyrem (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem (Sodium Oxybate) to Treat Fibromyalgia.

  • Bergamo, Lombardy, Italy

    A.O. Ospedale Papa Giovanni XXIII

  • Bergen, Hordaland, Norway

    Effectiveness of Ketamine in Malignant Neuropathic Pain Relief • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Bergen, Norway

    Bergen kommune • Haukeland University Hospital • University of Bergen

  • Berkeley, California, USA

    Sage Integrative Health • Alexander Shulgin Research Institute • Berkeley Center for the Science of Psychedelics (BCSP) • Graduate Theological Union

    Susan Barnes • Megan Kelly Smith, MFT • Dana Ullman, MPH, CCH

    Operations Manager • Psychiatry position • Development Director • Development Director • Development Director • Executive Director

    A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD • Correlates of Anxiety Associated With a Life-threatening Illness • Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Berlin, Germany

    atai Life Sciences • Introspect • Psychedelic Society Berlin • PsychonautWiki • Viridia Life Science • Charite University, Berlin, Germany • MIND Foundation • Empath Bio • OVID Health Systems • German Federal Ministry of Education and Research

    ATAI Life Sciences AG • Masawa Management • Berggruen Holdings

    Florian Brand • Simon Seibold • Joshua Haynes • Svenia Sauer • Natalie Holmes • Julia Meyer • Judy Godhart • Judith Mayer

    Internship - Business Operations • Business Operations & Strategy Manager (m/w/d) • Business Operations Intern • Business Associate • Working Student - Business Operations • Head of Investment (m/w/d) • Business Operations & Strategy Manager (m/w/d) • VP Human Resources/People • VP of Investment

    The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression • Ketamine-Induced Brain Changes and Their Modulation by Lamotrigine • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • A Safety and Efficacy Study of Xyrem (Sodium Oxybate) to Treat Fibromyalgia. • Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription • Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study • Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Berlin, New Jersey, USA

    A Study of Psilocybin for Major Depressive Disorder (MDD) • A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects • A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects • A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects • Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression • A Safety and Efficacy Study of Xyrem (Sodium Oxybate) to Treat Fibromyalgia. • A Safety and Efficacy Study of Xyrem in Subjects With Fibromyalgia • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Bern, Switzerland

    Psychedelic Society Switzerland • Schweizerischer Nationalfonds • University of Bern

    Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

  • Besançon, Bourgogne-Franche-Comté, France

    The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression

  • Bethesda, Maryland, USA

    National Institute on Drug Abuse (NIDA) • National Institute of Neurological Disorders and Stroke (NINDS) • National Institutes of Health Clinical Center (CC) • National Institute on Minority Health and Health Disparities (NIMHD) • National Institutes of Health (NIH) • National Institute of Mental Health (NIMH) • National Cancer Institute (NCI) • National Institute of General Medical Sciences (NIGMS) • National Institute of Nursing Research (NINR) • Mid-Atlantic Epilepsy and Sleep Center, LLC • National Center for Research Resources (NCRR) • National Institute on Deafness and Other Communication Disorders (NIDCD) • National Institute on Aging (NIA) • Walter Reed National Military Medical Center • Cannabics Pharmaceuticals

    Evaluating Ketamine and Psychological Sequelae • Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain • A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue • Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder • Mechanism of Action Underlying Ketamine s Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression • Effect of Ketamine on Fatigue Following Cancer Therapy • Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus • Rapid Antidepressant Effects of Ketamine in Major Depression • Neurobiology of Suicide • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Bethpage, New York, USA

    Dr. Richard Tscherne Tscherne, PHD

  • Bettendorf, Iowa, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Beverly Hills, California, USA

    Pacific Ketamine Institute

    Cat Meyer • Dr. Valerie Kanter • Dr. Jasmine Talei, ND • Dr. Michelle Haloossim, DACM MPH LAc • Sally Hayes

    Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Biberist, Solothurn, Switzerland

    Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Billings, Montana, USA

    Montana Psychiatry and Brain Health Center

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Bingham Farms, Michigan, USA

    Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor • A Safety and Efficacy Study of Xyrem (Sodium Oxybate) to Treat Fibromyalgia.

  • Birmingham, Alabama, USA

    University of Alabama at Birmingham

    Simran Ubhi

    Psilocybin-facilitated Treatment for Cocaine Use • Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures • A Study to Evaluate Ketamine for the Treatment of Rett Syndrome • Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea • Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus • A Study of Ketamine in Patients With Treatment-resistant Depression • miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome • Treatment of Suicidal Ideation With Intravenous Ketamine Infusion • Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery • Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression • Sequential Therapy for the Treatment of Severe Bipolar Depression. • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients • A Safety and Efficacy Study of Xyrem (Sodium Oxybate) to Treat Fibromyalgia. • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Birmingham, England, United Kingdom

    Psychedelic Society of Birmingham

  • Bismarck, North Dakota, USA

    Thrive Anesthesia Services

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Bixby, Oklahoma, USA

    Neuma Coaching

  • Blacksburg, Virginia, USA

    Virginia Polytechnic Institute and State University

  • Bloomingdale, Illinois, USA

    Premier Infusions

  • Bloomington, Illinois, USA

    Indiana University

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Bloomington, Indiana, USA

    Monique Brown, CLC

    Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  • Bloomington, Minnesota, USA

    HealthPartners Institute